ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Conditions
Advanced/Metastatic Solid Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Honor Health Research Institute, Scottsdale, Arizona, United States
Contact: Study coordinator (Sharma Sunil, MD)City of Hope National Medical Center, Duarte, California, United States
Contact: Study coordinator (Daneng Li, MD)Contact: Study coordinator (Marwan Fakih, MD)City of Hope Orange County, Irvine, California, United States
Contact: Study coordinator (Pashtoon Kasi, MD)Florida cancer specialist/Sarah Cannon Research Institute, Sarasota, Florida, United States
The Cleveland Clinic, Cleveland, Ohio, United States
Contact: Study coordinator (Smitha Krishnamurthi, MD)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (David Hong, MD)Contact: Study coordinator (Mary Trahan)Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Study coordinator (Rachael Safyan, MD)Fujian Cancer Hospital, Fuzhou, Fujian, China
Contact: Study coordinator (Yu Chen, MD)SunYat-Sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Ruihua Xu, MD)Hong Kong Humanity & Health Clinical Trial Center, Hong Kong, Hong Kong, China
Contact: Study coordinator (George Lau, MD)Prince of Wales Hospital, Hong Kong, Hong Kong, China
Contact: Study coordinator (Brigette B.Y Ma, MD)Dong -A University Hospital, Seogu, Busan Gwangyeogsi, South Korea
CHA Bundang Medical Center, CHA university, Seongnam, Gyeonggido, South Korea
Contact: Study coordinator (Hing Jae Chon, MD)Contact: Study coordinator (Song I Kang)The Catholic University of Korea Street. Vincent Hospital, Suwon, Gyeonggido, South Korea
Chungbuk National University Hospital, Cheongju-si, North Chungcheong, South Korea
Contact: Study coordinator (Ki Hyeong Lee, MD)Contact: Study coordinator (Hee Kyung Kim, MD)Samsung Medical Center, Seoul, Seoul Teugbyeolsi, South Korea
Contact: Study coordinator (Byoung Yong Shim, MD)Contact: Study coordinator (Jee Yun Lee, MD)Keimyung University Dongsan Hospital, Daegu, South Korea
Seoul National University Hospital, Seoul, South Korea
Contact: Study coordinator (Seock -Ah Im, MD)Contact: Study coordinator (Sae Won Han, MD)KangBuk Samsung Hospital, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Contact: Study coordinator (Sun Young Kim, MD)Contact: Study coordinator (Ko Eun- Young)Severance Hospital Yonsei University Health System, Seoul, South Korea
Contact: Study coordinator (Sang Joon Shin, MD)Contact: Study coordinator (Da Seul Lee)
Study leads
Jiping Zha, MD, PhD
Study Director
Adagene Inc